Serum MMP-9 levels were significantly upregulated in breast cancer patients compared to normal controls and high serum MMP-9 levels were significantly associated with poor prognostic factors, such as higher tumor size and lymph node metastasis, and lower relapse-free survival and OS rates (51). The gene discussed is MMP9; the disease is breast carcinoma.